Constrictive-Effusive Pericarditis Medication

  • Author: D Dirk Bonnema, MD; Chief Editor: Joseph L Fredi, MD   more...
 
Updated: Dec 5, 2011
 
 

Medication Summary

No specific medical therapy exists. Whenever possible, treatment is directed at the underlying cause. Intravascular volume status must not be decreased excessively in the presence of tamponade physiology; diuretics must not be applied indiscriminately. On the other hand, after pericardial drainage, diuretics may be useful with constrictive physiology and evidence of volume overload.

Proceed to Follow-up
 
 
Contributor Information and Disclosures
Author

D Dirk Bonnema, MD  Cardiology Fellow, Division of Cardiology, Department of Medicine, Medical University of South Carolina; Research Fellow, Division of Cardiology, Department of Medicine, Medical University of South Carolina

D Dirk Bonnema, MD is a member of the following medical societies: South Carolina Medical Association

Disclosure: Nothing to disclose.

Coauthor(s)

Terrence X O'Brien, MD, FACC  Professor of Medicine/Cardiology, Director, Clinical Cardiovascular Research, Medical University of South Carolina; Director, Echocardiography Laboratory, Veterans Affairs Medical Center of Charleston

Terrence X O'Brien, MD, FACC is a member of the following medical societies: American College of Cardiology, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, and South Carolina Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Eric Vanderbush, MD, FACC  Chief, Department of Internal Medicine, Division of Cardiology, Harlem Hospital Center; Clinical Assistant Professor of Cardiology, Columbia University College of Physicians and Surgeons

Eric Vanderbush, MD, FACC is a member of the following medical societies: American College of Cardiology and American Heart Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Ronald J Oudiz, MD, FACP, FACC, FCCP  Professor of Medicine, University of California, Los Angeles, David Geffen School of Medicine; Director, Liu Center for Pulmonary Hypertension, Division of Cardiology, LA Biomedical Research Institute at Harbor-UCLA Medical Center

Ronald J Oudiz, MD, FACP, FACC, FCCP is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Heart Association, and American Thoracic Society

Disclosure: Actelion Grant/research funds Clinical Trials + honoraria; Encysive Grant/research funds Clinical Trials + honoraria; Gilead Grant/research funds Clinical Trials + honoraria; Pfizer Grant/research funds Clinical Trials + honoraria; United Therapeutics Grant/research funds Clinical Trials + honoraria; Lilly Grant/research funds Clinical Trials + honoraria; LungRx Clinical Trials + honoraria; Bayer Grant/research funds Consulting

Amer Suleman, MD  Private Practice

Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Chief Editor

Joseph L Fredi, MD  Assistant Professor of Medicine, Director of Acute MI Program, Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center

Joseph L Fredi, MD is a member of the following medical societies: American College of Cardiology and American College of Physicians

Disclosure: Nothing to disclose.

Additional Contributors

Acknowledgment for support for this chapter is given to the Office of Research and Development, Medical Research Service, Ralph H. Johnson Department of Veterans Affairs Medical Center, and the Gazes Cardiac Research Institute, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina.

References

  1. Goldstein JA. Cardiac tamponade, constrictive pericarditis, and restrictive cardiomyopathy. Curr Probl Cardiol. Sep 2004;29(9):503-67. [Medline].

  2. Little WC, Freeman GL. Pericardial disease. Circulation. Mar 28 2006;113(12):1622-32. [Medline].

  3. Hancock EW. Subacute effusive-constrictive pericarditis. Circulation. Feb 1971;43(2):183-92. [Medline].

  4. Hoit BD. Management of effusive and constrictive pericardial heart disease. Circulation. Jun 25 2002;105(25):2939-42. [Medline].

  5. Lorell BH. Pericardial diseases. In: Brunwald E, ed. Heart Disease. 5th ed. Philadelphia, PA: WB Saunders; 1997:1496-505.

  6. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. Feb 28 2004;363(9410):717-27. [Medline].

  7. Spodick DH, Kumar S. Subacute constrictive pericarditis with cardiac tamponade. Dis Chest. Jul 1968;54(1):62-6. [Medline].

  8. Cameron J, Oesterle SN, Baldwin JC, Hancock EW. The etiologic spectrum of constrictive pericarditis. Am Heart J. Feb 1987;113(2 Pt 1):354-60. [Medline].

  9. Hancock EW. A clearer view of effusive-constrictive pericarditis. N Engl J Med. Jan 29 2004;350(5):435-7. [Medline].

  10. Maisch B. Pericardial diseases, with a focus on etiology, pathogenesis, pathophysiology, new diagnostic imaging methods, and treatment. Curr Opin Cardiol. May 1994;9(3):379-88. [Medline].

  11. Wood P. Chronic constrictive pericarditis. Am J Cardiol. Jan 1961;7:48-61. [Medline].

  12. Spodick DH. The Pericardium: A Comprehensive Textbook. New York, NY: Marcel Dekker; 1997:260-452.

  13. Shabetai R. Pericardial Disease: Etiology, Pathophysiology, Clinical Recognition, and Treatment. New York, NY: Churchill Livingstone; 1995:1024-35.

  14. Sagrista-Sauleda J, Angel J, Sanchez A, et al. Effusive-constrictive pericarditis. N Engl J Med. 2004;350(5):469-75. [Medline].

  15. Zagol B, Minderman D, Munir A, D'Cruz I. Effusive constrictive pericarditis: 2D, 3D echocardiography and MRI imaging. Echocardiography. Nov 2007;24(10):1110-4. [Medline].

  16. Akhter MW, Nuño IN, Rahimtoola SH. Constrictive pericarditis masquerading as chronic idiopathic pleural effusion: importance of physical examination. Am J Med. Jul 2006;119(7):e1-4. [Medline].

  17. Rafailidis PI, Prapas SN, Kasiakou SK, Costeas XF, Falagas ME. Effusive-constrictive calcific pericarditis associated with Streptococcus salivarius. Case report and review of the literature. Cardiol Rev. May-Jun 2005;13(3):113-7. [Medline].

  18. Fowler NO, Manitsas GT. Infectious pericarditis. Prog Cardiovasc Dis. Nov-Dec 1973;16(3):323-36. [Medline].

  19. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmüller R, Adler Y. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. Apr 2004;25(7):587-610. [Medline].

  20. Feigenbaum H, Armstrong W. Pericardial diseases. In: Feigenbaum's Echocardiography. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2004:260-9.

  21. Ha JW, Lee JD, Ko YG, Yun M, Rim SJ, Chung N. Images in cardiovascular medicine. Assessment of pericardial inflammation in a patient with tuberculous effusive constrictive pericarditis with 18F-2-deoxyglucose positron emission tomography. Circulation. Jan 3 2006;113(1):e4-5. [Medline].

  22. Maisch B, Pankuweit S, Brilla C, et al. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy: results from a pilot study. Clin Cardiol. Jan 1999;22(1 Suppl 1):I17-22. [Medline].

  23. Park GM, Lee JY, Kim YG, Boo SJ, Song JM, Kang DH, et al. Recurrent postoperative effusive-constrictive pericarditis associated with steroid discontinuation. J Cardiovasc Ultrasound. Sep 2009;17(3):102-5. [Medline]. [Full Text].

  24. Olson JE, Ryan MB, Blumenstock DA. Eleven years' experience with pericardial-peritoneal window in the management of malignant and benign pericardial effusions. Ann Surg Oncol. Mar 1995;2(2):165-9. [Medline].

  25. Olsen PS, Sorensen C, Andersen HO. Surgical treatment of large pericardial effusions. Etiology and long- term survival. Eur J Cardiothorac Surg. 1991;5(8):430-2. [Medline].

  26. Kolek M. Effusive-constrictive pericarditis post surgical revision for iatrogenic hemopericardium. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. Mar 2011;155(1):71-4. [Medline].

  27. Okayama S, Soeda T, Seno A, Watanabe M, Nakajima T, Uemura S, et al. Rare concurrence of apical hypertrophic cardiomyopathy and effusive constrictive pericarditis. Open Cardiovasc Med J. 2011;5:99-102. [Medline]. [Full Text].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.